Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
Screen a stock
TERMINAL
CE

CERSStockCerus Corp.

Nasdaq Global Market · Healthcare · US

$1.85 last close 2026-11-20
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment CERS's does — no target price to set, unlike a price alert.

Stable Ratio screen, 6 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it

Sharia status
COMPLIANT
Per our secondary compliance provider · assessed 2026-08-06
Assessed 2026-08-06
6 of 7 pass our own screen — the standards disagree
HTR non-permissible income <0.01%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
🔴 AVOID
The main driver: lagging the market by 11.1%, insider selling on the open market. Too many signals pointing the...
Scores: 2 bullish / 3 bearish
64
of 100
Setup confidence — system conviction, not win probabilityC

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure0 of 5 timeframes bullish · 95.7% aligned
VWAPPrice below VWAP ($1.92)
VolumeRelative volume 5.8× the 20-day average
Momentum10-day rate of change -4.0%
Overall readAVOID

Cerus Corp. (CERS) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-06). See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →

Market & analysts
Wall Street consensus
BUY
10 analysts
Institutional own.
73.3%
of shares
Momentum (10d)
-4.0%
rate of change
SMC grade
C · 64
95.7% aligned
<0.01%
Non-permissible income — HTR, from filings (2026-06-30)
C · 64
SMC grade — 95.7% timeframe alignment
-4.0%
Rate of change (10d)
BUY
Wall Street consensus (10)
73.3%
Institutional ownership

How the status reached this point

Compliant · status tracked since Nov 17, 2026

No change to CERS’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.

Read once a day from the status this page publishes, last on Nov 21, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $375.6M as of 2026-11-17. At the 2026-11-20 close it is about $391.8M (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing debt ratio would read 3.0% (3.1% at the stored cap, against a 30% line) and interest-bearing investments ratio would read 14.7% (15.4% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 3.09% 30.00% Pass(26.9pp buffer)
Interest-bearing investments 15.37% 30.00% Pass(14.6pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Usmani Pass 5 of 5 ratios pass
RatioValueThresholdResult
Interest-bearing debt 5.67% 33.00% Pass(27.3pp buffer)
Interest-bearing investments 28.20% 33.00% Pass(4.8pp buffer)
Non-liquid assets 56.87% at least 20.00% Pass(36.9pp above the floor)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Net liquid assets per share $8.3M under mkt cap $375.6M Pass
MSCI Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 5.67% 33.33% Pass(27.7pp buffer)
Cash + interest-bearing securities 28.20% 33.33% Pass(5.1pp buffer)
Accounts receivable 43.13% 33.33% Fail(9.8pp over)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
FTSE Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 0.00% 33.33% Pass(33.3pp buffer)
Cash + interest-bearing securities 28.20% 33.33% Pass(5.1pp buffer)
Accounts receivable 43.13% 50.00% Pass(6.9pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Dow Jones Islamic Market Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 3.01% 33.00% Pass(30.0pp buffer)
Cash + interest-bearing securities 14.98% 33.00% Pass(18.0pp buffer)
Accounts receivable 7.93% 33.00% Pass(25.1pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 3.06% 33.00% Pass(29.9pp buffer)
Cash + interest-bearing securities 15.20% 49.00% Pass(33.8pp buffer)
Accounts receivable 8.04% 49.00% Pass(41.0pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI M-Series Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 3.06% 33.33% Pass(30.3pp buffer)
Cash + interest-bearing securities 15.20% 33.33% Pass(18.1pp buffer)
Accounts receivable 23.24% 49.00% Pass(25.8pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

Usmani (% of total assets)investments ratio 4.8pts
AAOIFI Standard 21 (% of market cap)non permissible income ratio 5.0pts
Usmani (% of total assets)non permissible income ratio 5.0pts
MSCI Islamic Index (% of total assets)receivables ratio 9.8pts

The numbers the ratios are built from

Read from CERS's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $233.8M 2026-09-30 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $0 2026-09-30 no debt tag reported in 3+ years (treated as $0)
Cash and interest-bearing securitiesCash, equivalents and marketable securities $57.7M 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents, AvailableForSaleSecuritiesDebtSecuritiesCurrent
Total assetsBalance sheet total $204.7M 2026-09-30 Assets
Market capDenominator for AAOIFI $375.6M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $367.6M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $374.8M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $0 2026-09-30 no interest-income tag reported in 3+ years (treated as $0)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet as of 2026-09-30. Income statement as of 2026-09-30. Screened 2026-11-17.

Filing links appear after the next screen: this row was screened before filing citations were recorded.

  • Total assets$204.7M
    Assets · balance sheet as of 2026-09-30
  • Interest-bearing debt$0
    no debt tag reported in 3+ years (treated as $0) · balance sheet as of 2026-09-30
  • Cash and interest-bearing securities$57.7M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents, AvailableForSaleSecuritiesDebtSecuritiesCurrent · balance sheet as of 2026-09-30
  • Receivables$30.6M
    AccountsReceivableNetCurrent · balance sheet as of 2026-09-30
  • Revenue$233.8M
    RevenueFromContractWithCustomerExcludingAssessedTax · income statement as of 2026-09-30
  • Interest income (non-permissible)$0
    no interest-income tag reported in 3+ years (treated as $0) · income statement as of 2026-09-30
  • Market cap$375.6M
    Market-data quote at screen time, 2026-11-17 · not a filing figure, so no link

What changed, and when

Verdict history for CERS. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-11-17 Unverified → Fail filing re-screen
  • 2026-11-17 Unverified → Pass filing re-screen

Tracked since 2026-09-07.

Revenue by business segment

How CERS’s $233.8M of revenue for the fiscal year 2025-01-01 to 2025-12-31 splits across what it sells, as the company tags it in its own 10-K.

Fiscal year ended 2025-12-31
SegmentShareRevenue
Product 88.2% $206.1M
Government Contract 11.8% $27.7M

These are the company’s own segment names and figures. They do not say whether a line of business is permissible; our business-activity screen does.

Source: 10-K filed 2026-03-02 (accession 0001193125-26-085678), read from its XBRL on SEC EDGAR. Shares are of total revenue; subtotals and overlapping cuts the filing also tags are left out, so the lines add up to the total.

What would change the status

The headline verdict is the majority of the decided ratio standards — 6 pass and 1 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-17.

No standard's deciding ratio sits within 3 points of its line.

The ratios that move with the share price

AAOIFI's debt ratio (3.1% against a 30% line) would only fail if the market cap fell by 90%, to $38.7M. At the 2026-11-20 close it would read 3.0%.

AAOIFI's investments ratio is $57.7M cash and interest-bearing investments over a market cap of $375.6M (as of 2026-11-17), 15.4% against a 30% line.

At the 2026-11-20 close the market cap is about $391.8M (the stored cap moved by the share price since), so this ratio would read 14.7%; the line is -51% from there. The published status changes only when the company is re-screened.

It would fail if the market cap fell to $192.4M (-49%), about $0.95 a share against $1.86 implied by the screen's own figures.

AAOIFI would then fail; the majority verdict would stay Compliant (5 of 7 decided standards passing).

At the screen's market cap, cash and interest-bearing investments would have to rise by $55.0M to reach the line.

AAOIFI would then fail, and the majority verdict would move from Compliant to Not compliant (3 of 7 decided standards passing, counting every standard that divides the same figure).

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Medical Devices listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
ABTAbbott Laboratories $201.9B —
SYKStryker Corp. $125.7B —
MDTMedtronic Plc $117.8B —
BSXBoston Scientific Corp. $71.0B —
EWEdwards Lifesciences Corp $52.2B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold CERS

4 of the 227 funds whose filed holdings we currently hold own CERS shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns CERS.

You may already own it

Widely held U.S. index funds. If you own one, you own CERS through it. None of them is a Shariah fund; the last column is our look-through of each.

FundCERS in fundFund compliant by weight
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00% 54%
SCHB Schwab U.S. Broad Market ETF 0.00% 53%
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.00% 54%
Other funds
FundCERS in fundFund compliant by weight
SWSSX Schwab Small-Cap Index Fund 0.01% 31%

Sorted by CERS’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names CERS once, so a bond is not counted as the shares. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding CERS
InvestorFirmPositionWeightAs of
Cathie Wood ARK Investment Management $49M 0.3% 2026-09-30
David Shaw D. E. Shaw & Co. $11M 0.0% 2026-09-30
Ken Griffin Citadel Advisors $2M 0.0% 2026-09-30
Peter Brown Renaissance Technologies $1M 0.0% 2026-09-30
Steven Cohen Point72 Asset Management $0M 0.0% 2026-09-30
Israel Englander Millennium Management $0M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

3.282.882.492.091.692025-11-242026-05-272026-11-20

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
1.64
S2
1.75
S1
1.83
PIVOT
1.94
R1
2.02
R2
2.13
R3
2.21

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
2.00 – 2.56
±12.43% from 2.28, made 2026-10-04 · resolves 2026-10-11
STRONG SELL
from 19 indicators
78.6% of our last 30385 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsSELL
2 buy · 2 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)36.20NEUTRAL
Stochastic %K (14)4.29BUY
CCI (20)-94.45NEUTRAL
Williams %R (14)-95.71BUY
MACD (12,26,9)-0.02SELL
ROC (10)-8.42SELL
Momentum (10)-0.17SELL
EMA (10)1.97SELL
SMA (10)1.95SELL
EMA (20)2.07SELL
SMA (20)2.14SELL
EMA (30)2.15SELL
SMA (30)2.18SELL
EMA (50)2.26SELL
SMA (50)2.30SELL
EMA (100)2.38SELL
SMA (100)2.54SELL
EMA (200)2.34SELL
SMA (200)2.42SELL

About Cerus Corp.

Healthcare · Medical Devices

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced; and INTERCEPT Illuminator, an LED-based device for blood component treatment. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. The company was incorporated in 1991 and is headquartered in Concord, California.

cerus.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Verdict

🔴 AVOID

The main driver: lagging the market by 11.1%, insider selling on the open market. Too many signals pointing the wrong way. Wait for the picture to improve before committing capital.

Scores: 2 bullish / 3 bearish

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 64
⏰ 4H BEARISH 39
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min RANGING 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-4.0%
Rate of change (10d)
5.8×
Volume vs its 20-day average
-0.12
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

CLUSTER SELL   0 buys · 5 sells

Recent: Greenman William Mariner sold 5053036 sh @ $2.94 (2026-06-30); Jayaraman Vivek K sold 2232211 sh @ $3.16 (2026-07-16); Jayaraman Vivek K sold 1694348 sh @ $2.94 (2026-06-30)

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-17 · Asset managers net 895049 (-19081)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.